Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Cash from Investing Activities (2020 - 2026)

RxSight filings provide 6 years of Cash from Investing Activities readings, the most recent being -$9.6 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 828.33% to -$9.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 million, a 117.01% increase, with the full-year FY2025 number at $16.9 million, up 117.01% from a year prior.
  • Cash from Investing Activities hit -$9.6 million in Q4 2025 for RxSight, down from -$9.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $43.8 million in Q2 2022 to a low of -$115.6 million in Q2 2024.
  • Median Cash from Investing Activities over the past 5 years was $2.9 million (2023), compared with a mean of -$7.3 million.
  • Biggest five-year swings in Cash from Investing Activities: surged 2984.82% in 2023 and later crashed 2731.29% in 2024.
  • RxSight's Cash from Investing Activities stood at -$35.3 million in 2021, then surged by 129.44% to $10.4 million in 2022, then crashed by 56.12% to $4.6 million in 2023, then plummeted by 71.09% to $1.3 million in 2024, then plummeted by 828.33% to -$9.6 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$9.6 million (Q4 2025), -$9.0 million (Q3 2025), and $14.7 million (Q2 2025) per Business Quant data.